Live Breaking News & Updates on Karolinska development

Stay informed with the latest breaking news from Karolinska development on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Karolinska development and stay connected to the pulse of your community

Year-end Report - January-December 2023

STOCKHOLM – 16 February 2024. Karolinska Development AB today publishes its Year-end Report - January-December 2023. The full report is available on the Company's website. “2023 has been a year...

Stockholm , Sweden , Viktor-drvota , Karolinska-institutet , Karolinska-development-ab-nasdaq-stockholm , Us-national-institute-of-drug-abuse , Liver-international , Karolinska-development , Nasdaq-stockholm , Year-end-report , Modus-therapeutics , Umecrine-cognition

Karolinska Development's portfolio company AnaCardio

STOCKHOLM, SWEDEN January 17, 2024. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company AnaCardio has received...

Stockholm , Sweden , Swedish , Johan-dighed , Karolinska-institutet , Ann-helene-ljungstr , Viktor-drvota , Karolinska-development , B-health-ventures , Karolinska-development-ab-nasdaq-stockholm , Nasdaq-stockholm , Flerie-invest

Karolinska Development's portfolio company AnaCardio secures SEK 50 million as part of its Series A investment round

Karolinska Development's portfolio company AnaCardio secures SEK 50 million as part of its Series A investment round
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Sweden , Stockholm , Swedish , Ann-helene-ljungstr , Viktor-drvota , Johan-dighed , Karolinska-institutet , B-health-ventures , Karolinska-development-ab-nasdaq-stockholm , Karolinska-development , Nasdaq-stockholm , Flerie-invest

Karolinska Development's portfolio company OssDsign reports exceptional clinical data for its nanosynthetic bone graft product

Karolinska Development's portfolio company OssDsign reports exceptional clinical data for its nanosynthetic bone graft product
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Hungary , Stockholm , Sweden , Budapest , Viktor-drvota , Johan-dighed , Karolinska-institutet , Karolinska-development-ab-nasdaq-stockholm , Karolinska-development , Buda-health-clinic , National-center , Investment-fund

Karolinska Development's portfolio company OssDsign reports exceptional clinical data for its nanosynthetic bone graft product

STOCKHOLM, SWEDEN, January 9, 2024. Karolinska Development AB announces that the portfolio company OssDsign reports positive data from the clinical study TOP FUSION. Top-line results show a 93%...

Stockholm , Sweden , Hungary , Budapest , Viktor-drvota , Johan-dighed , Karolinska-institutet , Investment-fund , Buda-health-clinic , Drug-administration , National-center , Karolinska-development

Karolinska Development's portfolio company OssDsign reports exceptional clinical data for its nanosynthetic bone graft product

STOCKHOLM, SWEDEN, January 9, 2024. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces that the portfolio company OssDsign reports positive data from the clinical study TOP FUSION. Top-line results show a 93% spinal fusion rate at 12 months as assessed with CT by independent radiological review after surgery with the novel nanosynthetic bone graft OssDsign Catalyst. The data, that has been submitted to a peer-reviewed scientific journal, indicates that the use of OssDsign Catalyst lead

Hungary , Stockholm , Sweden , Budapest , Karolinska-institutet , Johan-dighed , Viktor-drvota , Investment-fund , Karolinska-development-ab-nasdaq-stockholm , Karolinska-development , Buda-health-clinic , Drug-administration

Karolinska Development's portfolio company OssDsign expects fourth-quarter revenues to exceed market estimates

STOCKHOLM, SWEDEN, December 6, 2023. Karolinska Development AB announces that the portfolio company OssDsign expects revenues for the fourth quarter of 2023 to exceed market expectations. Preliminary...

Stockholm , Sweden , Karolinska-institutet , Johan-dighed , Viktor-drvota , Drug-administration , Karolinska-development , Karolinska-development-ab-nasdaq-stockholm , Investment-fund , Nasdaq-stockholm , Ossdsign-catalyst , Ossdsign-cranial

Karolinska Development's portfolio company PharmNovo´s drug candidate PN6047 in a NIDA funded collaboration | 04.12.23

Karolinska Development's portfolio company PharmNovo´s drug candidate PN6047 in a NIDA funded collaboration | 04.12.23
finanzen.at - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanzen.at Daily Mail and Mail on Sunday newspapers.

Michigan , United-states , Sweden , Stockholm , Karolinska-institutet , Johan-dighed , Emily-jutkiewicz , Viktor-drvota , University-of-michigan , Karolinska-development-ab-nasdaq-stockholm , Professor-amynah-pradhan-at-washington-university , Us-national-institute-of-drug-abuse

Karolinska Development's portfolio company PharmNovo´s drug candidate PN6047 in a NIDA funded collaboration

Karolinska Development's portfolio company PharmNovo´s drug candidate PN6047 in a NIDA funded collaboration
sina.com.hk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sina.com.hk Daily Mail and Mail on Sunday newspapers.

Michigan , United-states , Stockholm , Sweden , Emily-jutkiewicz , Viktor-drvota , Karolinska-institutet , Johan-dighed , Us-national-institute-of-drug-abuse , Professor-amynah-pradhan-at-washington-university , University-of-michigan , Karolinska-development-ab-nasdaq-stockholm